(Q41906059)

13 October 2017

Guidance for fluorescence in situ hybridization testing in hematologic disorders (English)

1 reference

13 October 2017

0 references

Daynna J Wolff

1

1 reference

13 October 2017

Adam Bagg

2

1 reference

13 October 2017

Linda D Cooley

3

1 reference

13 October 2017

Gordon W Dewald

4

1 reference

13 October 2017

Betsy A Hirsch

5

1 reference

13 October 2017

Peter B Jacky

6

1 reference

13 October 2017

Kathleen W Rao

7

1 reference

13 October 2017

P Nagesh Rao

8

1 reference

13 October 2017

Association for Molecular Pathology Clinical Practice Committee

9

1 reference

13 October 2017

American College of Medical Genetics Laboratory Quality Assurance Committee

10

1 reference

13 October 2017

1 April 2007

1 reference

The Journal of Molecular Diagnostics

13 October 2017

1 reference

13 October 2017

9

1 reference

13 October 2017

2

1 reference

13 October 2017

134-143

1 reference

Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Cytogenetics in acute leukemia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Genomic aberrations and survival in chronic lymphocytic leukemia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Topoisomerase II inhibitor-related acute myeloid leukaemia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

A multicenter investigation with D-FISH BCR/ABL1 probes

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Biology and treatment of infant leukemias

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Preclinical validation of fluorescence in situ hybridization assays for clinical practice.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Genetics and cytogenetics of multiple myeloma: a workshop report

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemias.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1867444

Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marro

18 August 2018

1 reference

12 December 2020

Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia

1 reference

12 December 2020

Using Controls for Molecular Cytogenetic Testing in Clinical Practice

1 reference

12 December 2020

Molecular identification of CBFbeta-MYH11 fusion transcripts in an AML M4Eo patient in the absence of inv16 or other abnormality by cytogenetic and FISH analyses--a rare occurrence

1 reference

12 December 2020

The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL

1 reference

12 December 2020

Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia

1 reference

12 December 2020

Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis

1 reference

12 December 2020

Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites

1 reference

12 December 2020

A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes

1 reference

12 December 2020

Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Test and Technology Transfer Committee

1 reference

12 December 2020

Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia

1 reference

12 December 2020

10.2353/JMOLDX.2007.060128

Identifiers

DOI

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

17384204

1 reference